Panacea Biotec Ltd approves Q2 FY27 results, reporting consolidated net profit of ₹11.91 crore on revenue of ₹189.67 crore.
- Consolidated revenue rose 34.4% year on year but fell 5.0% sequentially.
- Net profit compared with ₹2.20 crore in Q1 FY27 and a ₹14.01 crore loss in Q2 FY26; exceptional income was ₹2.70 crore.
- Auditors issued unmodified limited-review reports; notes flag going-concern uncertainty for the standalone company due to negative retained earnings.
